Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Leukemia, Myeloid, Acute 4Breast Neoplasms 4Lung Neoplasms 3Neoplasm Metastasis 2Tissue Adhesions 1Solid Tumor Refractory to Standard Therapy 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Platinum Resistant Ovarian Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neutropenia 1Neoplasms 1Myoma 1Myelodysplastic Syndromes 1Melanoma 1Lymphopenia 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1Leiomyoma 1Hearing Loss 1Febrile Neutropenia 1Fatigue 1

Interventions

Megestrol Acetate 2ostarine 1clazakizumab 1anamorelin 1alkaloid GB18 1Sodium Chloride 1Infliximab 1Gemcitabine 1Food 1Dietary Supplements 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cachexia × Sodium Chloride × Clear all
NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed
124 enrolled
Thoracic

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡